Amedisys, Inc. (AMED)
| Market Cap | 3.32B |
| Revenue (ttm) | 2.40B |
| Net Income (ttm) | 85.63M |
| Shares Out | 32.89M |
| EPS (ttm) | 2.58 |
| PE Ratio | 39.17 |
| Forward PE | 20.21 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 286,967 |
| Open | 100.96 |
| Previous Close | 100.95 |
| Day's Range | 100.73 - 101.00 |
| 52-Week Range | 82.15 - 101.01 |
| Beta | 0.90 |
| Analysts | Hold |
| Price Target | 100.67 (-0.28%) |
| Earnings Date | Jul 29, 2025 |
About AZPN
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for a... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for AMED stock is "Hold." The 12-month stock price target is $100.67, which is a decrease of -0.28% from the latest price.
News
UnitedHealth to sell off 164 locations to settle US challenge to Amedisys deal
UnitedHealth Group has agreed to sell off 164 hospice and home health locations to resolve U.S. antitrust concerns over its $3.3 billion acquisition of Amedisys , the U.S. Justice Department said on T...
Amedisys: Thoughts On UnitedHealth Merger, Plus Underlying Factors
AMED's planned merger with UnitedHealth remains on the rocks with regulatory overhang still an issue. The deal is also asymmetrically weighted in UNH's favor, with the latter up for no penalty if it f...
Amedisys Reports Second Quarter 2025 Financial Results
BATON ROUGE, La., July 29, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2025.
Amedisys Reports First Quarter 2025 Financial Results
BATON ROUGE, La., April 23, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2025.
Amedisys Reports Fourth Quarter and Year End 2024 Financial Results
BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024.
Amedisys Honors 47 Employees With Annual Spirit of Excellence Award
BATON ROUGE, La., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care services, has recognized 47 employees with the presti...
Amedisys, UnitedHealth Group Extend Deadline To Complete $3.3B Merger
UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Department of Justice moved to block it.
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Amedisys Inc AMED shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated UNH.
UnitedHealth, Amedisys extend deadline to close $3.3 billion deal
UnitedHealth and Amedisys have agreed to extend the deadline to close their $3.3 billion merger agreement to next year, a filing showed on Friday, as the deal faces close scrutiny from the U.S. Depart...
US sues to block UnitedHealth's $3.3 bln purchase of Amedisys
The Justice Department and three U.S. states filed a lawsuit on Tuesday to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc over concern the deal would harm competition in the market f...
US Justice Department preps suit over UnitedHealth-Amedisys deal, Bloomberg News reports
The U.S. Justice Department is moving to block UnitedHealth Group's $3.3 billion purchase of Amedisys Inc. over concerns the deal would harm competition in the market for home health services, Bloombe...
Amedisys Reports Third Quarter 2024 Financial Results
BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024.
Amedisys has earned the 2023 SHPBest™ Patient Satisfaction Awards
BATON ROUGE, La., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, has 92 home health and hospice care cen...
Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordinatio...
Amedisys Reports Second Quarter 2024 Financial Results
BATON ROUGE, La., July 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2024.
Amedisys Reports First Quarter 2024 Financial Results
BATON ROUGE, La., April 24, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period ended March 31, 2024.
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys
Amedisys said on Tuesday Oregon's health authority has started a review of UnitedHealth Group's $3.3 billion acquisition of the home health and hospice caregiver.
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
BATON ROUGE, La., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2023.
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis
BATON ROUGE, La., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is now offering advanced molecular testi...
Amedisys, Inc.: Why Stock Is A Hold Pending Agency Review
Amedisys, Inc. is set to be acquired by UnitedHealth Group in a $3.29 billion merger agreement. Some US legislators have called for further scrutiny of the merger, citing concerns of increased market ...
Amedisys Reports Third Quarter 2023 Financial Results
BATON ROUGE, La., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2023.
Amedisys Celebrates National Quality Week
Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care Held October 15-21, this Observance Shines a Light on Our Commitment to Quality Care
Amedisys Recognizes Suicide Prevention Awareness Month and Promotes the 988 Suicide & Crisis Lifeline
BATON ROUGE, La., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice and high-acuity care in the home, is proud to recognize September as Suici...
Amedisys Reports Second Quarter 2023 Financial Results
BATON ROUGE, La., July 26, 2023 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2023.
UnitedHealth's Amedisys Deal Come as Home Health and Data Cement Care Ecosystems
In healthcare, the latest acquisition brings to mind that old Fred Astaire song lyric: “Won't you change partners and dance with me?” On Monday, as had been reported here, Amedisys, the home health an...